...High Pharma Corporate Activity: The pharmaceutical sector has been a focus for M&A this year. Key themes underlying the further round of consolidation in the global pharmaceutical industry are the search for scale in consumer health care, focus on R&D productivity to manage the increasing costs and risks of bringing new drugs to market, and tax benefits. Value-Based Healthcare Focus: Pharma companies continue to adjust and develop their business models to compete in the "new health economy", with a strong emphasis on patient value as a basis for reimbursement. They are also encountering challenges and opportunities from growing global markets as emerging economies open and develop their healthcare systems. Biosimilar Opportunities Driving Generics: Projected growth in the generic drugs market will arise from significant opportunities for the biosimilar segment in EU and the US. According to sales data from IMS Health, 12 biologics compounds that generate around USD72bn in sales will face...
